Results 151 to 160 of about 4,368 (201)

Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study. [PDF]

J Clin Med
Güven AT, Yadigar S, Özdede M, Akgür S, Arslan F, Sezen M, Özcan B, Ayaz EY, Doğantekin B, Atay İ, Değer SM, Demir M, Koyuncu S, Yılmaz Ü, İnci A, Çolak H, Demirelli B, Tuğlular S, Oguz EG, Ayli MD, Avanaz E, Yılmaz F, Doğan B, Karaköse S, Karakan MŞ, Demirci BG, Türkmen K, Baloğlu İ, Batmazoğlu M, Mert M, Aydın E, Aydın FY, Parmaksız E, Özdemir P, Ediz B, Aydın Z, Demir ME, Sezer S, Ünver S, Baykal Ö, Akman B, Altuntaş A, İslam M, Koçak SY, Mert M, Dursun B, Eren N, Demir SB, Bilgiç MA, Erdut A, Keskin G, Horoz M, Şahin AZ, Tekinyıldız M, Duranay M, Yalın SF, Umut HMY, Altunok M, Sarı R, Sarı F, Torun D, Kahvecioğlu S, Karatutlu AS, Akagün T, Çelik H, Kazan S, Öztürk İ, Polat M, Aydın MF, Meşe M, Demirezen A, Derici Ü, Altun E, Bakırdöğen S, Kara E, Akgöl C, Aykent MB, İlter A, Ekmekci A, Ulu S, Arıcı M, Şengül E, Bakır EA.   +82 more
europepmc   +1 more source

Finerenone and Blood Pressure in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical Trial.

JAMA Cardiol
Ostrominski JW, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson A, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Brinker M, Schloemer P, Hofmeister L, McMurray JJV, Solomon SD, Vaduganathan M.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Finerenone

Vnitřní lékařství, 2023
In developed countries, diabetes mellitus (DM) is one of the main causes of end stage renal disease (ESRD). In addition, the development of chronic kidney disease (CKD) further increases the already significantly increased cardiovascular (CV) risk in patients with diabetes.
Jan, Vachek, Vladimír, Tesař
openaire   +3 more sources

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes [PDF]

Hypertension, 2022
Background: Chronic kidney disease is frequently associated with hypertension and poorly controlled blood pressure can lead to chronic kidney disease progression.
Luis Miguel Ruilope, Rajiv Agarwal, Peter Rossing   +2 more
exaly   +4 more sources

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports, 2022
Introduction: FIDELIO-DKD (Finerenone in reducing kiDnEy faiLure and disease prOgression in Diabetic Kidney Disease) investigated the nonsteroidal, selective mineralocorticoid receptor (MR) antagonist finerenone in patients with CKD and type 2 diabetes ...
Bertram Pitt, Rajiv Agarwal, Kieran Mccafferty   +2 more
exaly   +1 more source

Finerenon

Dialyse aktuell, 2021
Die diabetische Nephropathie, eine Manifestation der diabetischen Mikroangiopathie, ist weiterhin die häufigste Ursache der terminalen dialysepflichtigen Niereninsuffizienz in den Industrienationen. Dies zeigen u. a. aktuelle Daten des Registers der „European Renal Association – European Dialysis and Transplant Association“ (ERA-EDTA) 1.
openaire   +1 more source